Microglial activation‐mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease

The etiology of sporadic Parkinson's disease (PD) remains unknown. Increasing evidence has suggested a role for inflammation in the brain in the pathogenesis of PD. However, it has not been clearly demonstrated whether microglial activation, the most integral part of the brain inflammatory process, will result in a delayed and progressive degeneration of dopaminergic neurons in substantia nigra, a hallmark of PD. We report here that chronic infusion of an inflammagen lipopolysaccharide at 5 ng/h for 2 weeks into rat brain triggered a rapid activation of microglia that reached a plateau in 2 weeks, followed by a delayed and gradual loss of nigral dopaminergic neurons that began at between 4 and 6 weeks and reached 70% by 10 weeks. Further investigation of the underlying mechanism of action of microglia‐mediated neurotoxicity using rat mesencephalic neuron‐glia cultures demonstrated that low concentrations of lipopolysaccharide (0.1–10 ng/mL)‐induced microglial activation and production of neurotoxic factors preceded the progressive and selective degeneration of dopaminergic neurons. Among the factors produced by activated microglia, the NADPH oxidase‐mediated release of superoxide appeared to be a predominant effector of neurodegeneration, consistent with the notion that dopaminergic neurons are particularly vulnerable to oxidative insults. This is the first report that microglial activation induced by chronic exposure to inflammagen was capable of inducing a delayed and selective degeneration of nigral dopaminergic neurons and that microglia‐originated free radicals play a pivotal role in dopaminergic neurotoxicity in this inflammation‐mediated model of PD.

[1]  W. Foege,et al.  1918 INFLUENZA, ENCEPHALITIS LETHARGICA, PARKINSONISM , 1982, The Lancet.

[2]  G. Levi,et al.  Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide , 1998, Progress in Neurobiology.

[3]  S. Daniel,et al.  Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.

[4]  A. Graybiel,et al.  The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.

[5]  L. Swanson The Rat Brain in Stereotaxic Coordinates, George Paxinos, Charles Watson (Eds.). Academic Press, San Diego, CA (1982), vii + 153, $35.00, ISBN: 0 125 47620 5 , 1984 .

[6]  E. Hirsch,et al.  FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces, In Vitro, Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells , 1999, The Journal of Neuroscience.

[7]  T. Peng,et al.  Mitochondrial dysfunction in Parkinson's disease. , 1999, Biochemical Society symposium.

[8]  S. Yang,et al.  Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide. , 2000, The Journal of pharmacology and experimental therapeutics.

[9]  W. Tatton,et al.  Etiology and pathogenesis of Parkinson's disease. , 1999, Annual review of neuroscience.

[10]  Stanley J. Watson,et al.  The rat brain in stereotaxic coordinates (2nd edn) by George Paxinos and Charles Watson, Academic Press, 1986. £40.00/$80.00 (264 pages) ISBN 012 547 6213 , 1987, Trends in Neurosciences.

[11]  P. Kidd,et al.  Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management. , 2000, Alternative medicine review : a journal of clinical therapeutic.

[12]  M. Vawter,et al.  TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid. , 1996, Experimental neurology.

[13]  P C O'Brien,et al.  Brain injury and neurologic sequelae , 1991, Neurology.

[14]  J. Farber,et al.  Mechanisms of cell injury by activated oxygen species. , 1994, Environmental health perspectives.

[15]  I. Pérez-Otaño,et al.  Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures , 1995, Brain Research.

[16]  F. Aloisi,et al.  The role of microglia and astrocytes in CNS immune surveillance and immunopathology. , 1999, Advances in experimental medicine and biology.

[17]  H. Mori [Postencephalitic parkinsonism]. , 1999, Ryoikibetsu shokogun shirizu.

[18]  S. Yang,et al.  Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage. , 2001, The Journal of pharmacology and experimental therapeutics.

[19]  M. Carson,et al.  ALS, SOD and peroxynitrite , 1993, Nature.

[20]  E. Hirsch,et al.  FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. , 1999, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[21]  G. Kreutzberg Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[22]  M. Marmot,et al.  Could Parkinson's disease follow intra-uterine influenza?: a speculative hypothesis. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[23]  W. Weiner,et al.  Trauma as an etiology of parkinsonism: A historical review of the concept , 1988, Movement disorders : official journal of the Movement Disorder Society.

[24]  Jau-Shyong Hong,et al.  Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures , 1998, Journal of Neuroimmunology.

[25]  E. Hirsch Glial cells and Parkinson’s disease , 2000, Journal of Neurology.

[26]  INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY , 1976 .

[27]  J. Cano,et al.  The Single Intranigral Injection of LPS as a New Model for Studying the Selective Effects of Inflammatory Reactions on Dopaminergic System , 2000, Neurobiology of Disease.

[28]  P. Jenner,et al.  Understanding cell death in parkinson's disease , 1998, Annals of neurology.

[29]  M. Vawter,et al.  TGFβ1 and TGFβ2 Concentrations Are Elevated in Parkinson's Disease in Ventricular Cerebrospinal Fluid , 1996, Experimental Neurology.

[30]  Bin Liu,et al.  Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. , 2000, The Journal of pharmacology and experimental therapeutics.

[31]  Y. Hannun,et al.  Glutathione Regulation of Neutral Sphingomyelinase in Tumor Necrosis Factor-α-induced Cell Death* , 1998, The Journal of Biological Chemistry.

[32]  M. Yahr,et al.  Postencephalitic parkinsonism – a review , 1998, Journal of Neural Transmission.

[33]  J. Stolk,et al.  Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. , 1994, American journal of respiratory cell and molecular biology.

[34]  M. Polymeropoulos Autosomal dominant Parkinson’s disease , 1998, Journal of Neurology.

[35]  N. Wood,et al.  The genetics of Parkinson's disease. , 2000, Current opinion in genetics & development.

[36]  V. Perry,et al.  Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain , 1990, Neuroscience.

[37]  P. Dobrzanski,et al.  Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease , 1998, Brain Research.

[38]  B. Babior NADPH oxidase: an update. , 1999, Blood.

[39]  J. Mong,et al.  Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures , 1994, Neuropharmacology.

[40]  J. Rogers,et al.  A Perspective on Inflammation in Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[41]  B. Liu,et al.  Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons , 2002, The Journal of Neuroscience.

[42]  D. Dickson,et al.  Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease , 1993, Glia.

[43]  C. Raine,et al.  Multiple sclerosis: immune system molecule expression in the central nervous system. , 1994, Journal of neuropathology and experimental neurology.

[44]  T. Dawson,et al.  Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease , 2000, Neurobiology of Disease.

[45]  W. Streit,et al.  Microglial Response to Brain Injury: A Brief Synopsis , 2000, Toxicologic pathology.

[46]  J. Cano,et al.  Lipopolysaccharide Intranigral Injection Induces Inflammatory Reaction and Damage in Nigrostriatal Dopaminergic System , 1998, Journal of neurochemistry.

[47]  T. Molitor,et al.  Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. , 1992, Journal of immunology.

[48]  G. Bing,et al.  Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats , 2000, Neuroscience.

[49]  P. Carvey,et al.  In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain , 2002, Movement disorders : official journal of the Movement Disorder Society.

[50]  P. Mcgeer,et al.  Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.

[51]  C. Fall,et al.  Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. , 1997, Biochimica et biophysica acta.

[52]  A. Graybiel,et al.  The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. , 1999, Brain : a journal of neurology.

[53]  G. Baltuch,et al.  Microglia as mediators of inflammatory and degenerative diseases. , 1999, Annual review of neuroscience.

[54]  Jau-Shyong Hong,et al.  Molecular consequences of activated microglia in the brain: overactivation induces apoptosis , 2001, Journal of neurochemistry.

[55]  B. Babior NADPH Oxidase: An Update , 1999 .

[56]  B. Liu,et al.  Role of Nitric Oxide in Inflammation‐Mediated Neurodegeneration , 2002, Annals of the New York Academy of Sciences.

[57]  James P. O'Callaghan,et al.  Brain injury in a dish: a model for reactive gliosis , 1994, Trends in Neurosciences.

[58]  J. Guralnik,et al.  Documented head injury in early adulthood and risk of Alzheimer’s disease and other dementias , 2000, Neurology.

[59]  R. Mohney,et al.  Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia , 2000, The Journal of Neuroscience.

[60]  V. Massey The microestimation of succinate and the extinction coefficient of cytochrome c. , 1959, Biochimica et biophysica acta.